The Conversation·3 min read·medium

We designed a new way to build miniature fluidic devices to enable personalized cancer treatment

A
Arindom Sen
We designed a new way to build miniature fluidic devices to enable personalized cancer treatment
AI Summary

Researchers at the University of Calgary have developed a cost-effective method for manufacturing microfluidic 'tumour-on-a-chip' devices. This technology allows for the simulation of individual patient tumors to test personalized cancer treatments outside the body.

Why it matters

By lowering the manufacturing costs of these devices, this innovation could make personalized cancer therapy more accessible and effective for a broader range of patients.

Dive DeeperCreate a free account to unlock

Researchers Sara Hassanpour Tamrin (left) and Arindom Sen (right) discuss the pattern of tiny channels used in their new method for making microfluidic devices. (Joe McFarland/University of Calgary) We designed a new way to build miniature fluidic devices to enable personalized cancer treatment Published: September 8, 2026 3:57pm EDT https://theconversation.com/we-designed-a-new-way-to-build-miniature-fluidic-devices-to-enable-personalized-cancer-treatment-290197 https://theconversation.com/we-designed-a-new-way-to-build-miniature-fluidic-devices-to-enable-personalized-cancer-treatment-290197 Link copied Share article Share article

Copy link Email Bluesky Facebook WhatsApp Messenger LinkedIn X (Twitter) Print article

There is no “one-size-fits-all” treatment for patients living with cancer . Cancer occurs when normal cells in the body genetically mutate and transform into abnormal cells that divide uncontrollably.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealthtechnology

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in